网站地图
[pagelist exclude=”349,367,4220,3637,1905,1909,1911,1913,70″]
新闻
Early trial results support ongoing TherVacB hepatitis B patient study
New early clinical trial results support the ongoing TherVacB patient study for chronic hepatitis B.
It’s time for action, it’s World Hepatitis Day 2024!
Every year, 1.3 million people lose their lives to hepatitis. New data from the World Health Organization shows the number of deaths is rising. The TherVacB team is not waiting for change. Together with researchers from the D-Solve consortium and supporting partners,...
Researchers from “IP-cure-B” & “TherVacB” continue the dialogue to advance elimination of chronic hepatitis B
Researchers from the two EC-funded projects ‘IP-cure-B – Take care of your health’ and ‘TherVacB - A therapeutic vaccine to cure Hepatitis B’ continue their collaboration to jointly tackle some of the major challenges in the therapy of viral hepatitis.Building on a...